Shanghai INT Medical Instruments to acquire controlling stake

Shanghai INT Medical Instruments Co., Ltd. announced a discloseable transaction involving the proposed acquisition of a controlling stake in a target company focused on aortic and peripheral vascular interventional medical devices. The company has conditionally agreed to acquire 51.70% equity interest in the target company for RMB324.04 million. In conjunction with Chenyue Weixin, the purchasers will acquire a total of 81.83% equity in the target company for RMB512.84 million. Chenyue Weixin (as the Purchasers) will also make a further capital injection of no less than RMB150.00 million. Following completion, the target company will become a non-wholly owned subsidiary of Shanghai INT. The acquisition is subject to standard conditions precedent, including due diligence, regulatory approvals, and adjustments to the target company's governance structure.